Cargando…
Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients
AIMS: A close association has been demonstrated between increased cardiovascular risk and high asymmetric dimethylarginine (ADMA) levels in type 2 diabetes mellitus (DM) patients. We planned to measure serum ADMA levels in type 2 DM patients using vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhib...
Autores principales: | Cakirca, Mustafa, Karatoprak, Cumali, Zorlu, Mehmet, Kiskac, Muharrem, Kanat, Mustafa, Cikrikcioglu, Mehmet Ali, Soysal, Pinar, Hursitoglu, Mehmet, Camli, Ahmet Adil, Erkoc, Reha, Abdul-Ghani, Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931658/ https://www.ncbi.nlm.nih.gov/pubmed/24627624 http://dx.doi.org/10.2147/DDDT.S52545 |
Ejemplares similares
-
A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
por: Kiskac, Muharrem, et al.
Publicado: (2013) -
Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy
por: Zorlu, Mehmet, et al.
Publicado: (2013) -
Factor XI deficiency diagnosed following use of adalimumab
por: Cetin, Guven, et al.
Publicado: (2014) -
Serum endocan levels in women with restless legs syndrome
por: Celik, Kenan, et al.
Publicado: (2015) -
Evaluation of the relationship between vitamin D level and adropin, IL-1β, IL-6, and oxidative status in women
por: ZORLU, Mehmet, et al.
Publicado: (2022)